Alliance Pharma (APH) Sets New 1-Year High at $63.50
Shares of Alliance Pharma plc (LON:APH) reached a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 63.50 ($0.85) and last traded at GBX 62.75 ($0.84), with a volume of 202329 shares changing hands. The stock had previously closed at GBX 62.50 ($0.84).
A number of analysts have recently weighed in on the stock. Numis Securities reaffirmed a “buy” rating and set a GBX 60 ($0.80) price target on shares of Alliance Pharma in a report on Wednesday, September 13th. Investec assumed coverage on shares of Alliance Pharma in a report on Wednesday, September 13th. They set a “buy” rating and a GBX 59 ($0.79) price target for the company. N+1 Singer reaffirmed a “not rated” rating on shares of Alliance Pharma in a report on Wednesday, September 13th. Finally, FinnCap reaffirmed a “buy” rating and set a GBX 58 ($0.78) price target on shares of Alliance Pharma in a report on Thursday, September 14th.
The firm has a market cap of $297.63 and a P/E ratio of 1,255.00.
Alliance Pharma Company Profile
Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international.
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.